When is a diagnosis of sclerosing adenosis acceptable at core biopsy?

被引:35
|
作者
Gill, HK
Ioffe, OB
Berg, WA
机构
[1] Univ Maryland, Dept Radiol, Baltimore, MD 21201 USA
[2] Johns Hopkins Univ, Sch Med, Dept Radiol, Baltimore, MD 21205 USA
[3] Univ Maryland, Dept Pathol, Baltimore, MD 21201 USA
[4] Univ Maryland, Greenebaum Canc Ctr, Baltimore, MD 21201 USA
关键词
breast; biopsy; diseases;
D O I
10.1148/radiol.2281020447
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
PURPOSE: To determine concordance of imaging findings and diagnosis of sclerosing adenosis at histopathologic core biopsy and to establish the accuracy of core biopsy when cancer was coexistent. MATERIALS AND METHODS: From a database of 1,166 percutaneous biopsies in which sclerosing adenosis was reported, 88 (7.5%) lesions were identified, and imaging and histopathologic findings were reviewed for concordance. Sclerosing adenosis proved to be a minor component at core biopsy for 44 lesions; including one invasive ductal carcinoma, one ductal carcinoma in situ (DOS), one focus of atypical ductal hyperplasia (ADH); and one atypical lobular hyperplasia. Sclerosing 7 adenosis was a major (greater than or equal to50%) component for 44 lesions;; including four malignancies; all DOS manifested as clustered calcifications (pleomorphic [n = 2] or amorphous [n = 2]), and seven foci of ADH manifested as amorphous calcifications. In 30 patients with 33 lesions Without atypia or malignancy, sclerosing adenosis was the major finding at core biopsy (21 lesions at 14-gauge core biopsy and 12 at 11-gauge vacuum-assisted biopsy); these patients formed the study population. Mammographic (33 lesions) and sonographic (18 lesions) features were recorded. Twenty-seven lesions had at least 20-month follow-up (n = 25) or excision (n = 2). RESULTS: One speculated mass,was considered discordant and was excised, showing a prospectively unrecognized radial sclerosing lesion with several 2-5-mm foci of invasive tubular and lobular carcinoma. Seventeen (53%) of 32 lesions manifested. as masses; 10 (59%) were circumscribed, five (29%) were indistinctly marginated (one with punctate calcifications), and two (12%) were partially circumscribed and partially obscured (one with amorphous calcifications). Fifteen (47%) lesions-manifested as clustered calcifications; nine (60%) were amorphous and indistinct,, four (27%) were pleomorphic; and two (13%) were punctate. Of 27 lesions with acceptable follow-up; 26 (96%) were believed to have been accurately sampled at core biopsy. Of six radial sclerosing lesions associated with the original 88 lesions,;only three (50%) were prospectively recognized. CONCLUSION: Sclerosing adenosis is an acceptable result at core biopsy of circumscribed masses and nonpalpable indistinctly marginated masses and for clustered amorphous, pleomorphic; and punctate calcifications: Recognition and reporting of coexistent radial sclerosing: lesions is encouraged and may prompt excision. Malignancy can be seen with sclerosing adenosis; core biopsy was accurate in six (86%) of seven coexistent malignancies in this series. (C) RSNA, 2003.
引用
收藏
页码:50 / 57
页数:8
相关论文
共 50 条
  • [1] Sclerosing adenosis of the breast: radiologic appearance and efficiency of core needle biopsy
    Taskin, Fusun
    Koseoglu, Kutsi
    Unsal, Alparslan
    Erkus, Muhan
    Ozbas, Serdar
    Karaman, Can
    DIAGNOSTIC AND INTERVENTIONAL RADIOLOGY, 2011, 17 (04) : 311 - 316
  • [2] Carcinoma In Situ Involving Sclerosing Adenosis on Core Biopsy: Diagnostic Pearls to Aid the Practicing Clinician and Avoid Overtreatment
    Dana Richards
    Alberto A. Ayala
    Yun Wu
    Lavinia P. Middleton
    Oncology and Therapy, 2020, 8 : 81 - 89
  • [3] Carcinoma In Situ Involving Sclerosing Adenosis on Core Biopsy: Diagnostic Pearls to Aid the Practicing Clinician and Avoid Overtreatment
    Richards, Dana
    Ayala, Alberto A.
    Wu, Yun
    Middleton, Lavinia P.
    ONCOLOGY AND THERAPY, 2020, 8 (01) : 81 - 89
  • [4] Cytological diagnosis of sclerosing adenosis of breast: Diagnostic challenges and literature review
    Sharma, Tanya
    Chaurasia, Jai Kumar
    Kumar, Vinay
    Mukhopadhyay, Sramana
    Joshi, Deepti
    CYTOPATHOLOGY, 2021, 32 (06) : 827 - 830
  • [5] Atypical apocrine adenosis diagnosed on breast core biopsy: implications for management
    Calhoun, Benjamin C.
    Booth, Christine N.
    HUMAN PATHOLOGY, 2014, 45 (10) : 2130 - 2135
  • [6] Upregulation of ATM in sclerosing adenosis of the breast
    Clarke, RA
    Kairouz, R
    Watters, D
    Lavin, MF
    Kearsley, JH
    Lee, CS
    JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY, 1998, 51 (04): : 224 - 226
  • [7] IMPACT OF STEREOTAXIC CORE BREAST BIOPSY ON COST OF DIAGNOSIS
    LIBERMAN, L
    FAHS, MC
    DERSHAW, DD
    BONACCIO, E
    ABRAMSON, AF
    COHEN, MA
    HANN, LE
    RADIOLOGY, 1995, 195 (03) : 633 - 637
  • [8] When is core breast biopsy or fine-needle aspiration not enough
    Berg, WA
    RADIOLOGY, 1996, 198 (02) : 313 - 315
  • [9] Sclerosing adenosis:: mammographic and ultrasonographic findings with clinical and histopathological correlation
    Günhan-Bilgen, I
    Memis, A
    Üstün, EE
    Özdemir, N
    Erhan, Y
    EUROPEAN JOURNAL OF RADIOLOGY, 2002, 44 (03) : 232 - 238
  • [10] Sclerosing Adenosis of the Breast: Report of Two Cases and Review of the Literature
    Cucci, Eleonora
    Santoro, Angela
    Di Gesu, Cinzia
    Di Cerce, Renato
    Sallustio, Giuseppina
    POLISH JOURNAL OF RADIOLOGY, 2015, 80 : 122 - 127